GSK3B and cancer: Given its functions in non-transformed cells, activation of GSK3β has long been hypothesized to suppress the development and progression of cancer[137-139], thereby posing a challenge to pharmaceutical industries and clinical oncologists aiming to develop and apply GSK3β inhibitors for cancer treatment.